Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The leading causes of CKD were Nephrosclerosis and Diabetic Nephropathy.Baseline patient characteristicsTotalDialysis modalityPDHD p Characteristic(N = 67)(N = 22)(N = 45)Age, years59 ± 1559 ± 1758 ± 14NSMale, %53.754.553.3NSWhite, %63.871.459.5NSPrimary renal disease, % Nephrosclerosis30.822.734.9NS Diabetic Nephropathy24.622.725.6 Glomerulonephritis12.39.114.0 Others and unknown32.345.525.5Comorbidities, % Diabetes41.540.941.9NS Hypertension81.577.383.7NS Myocardial infarction10.64.513.6NS Stroke4.506.8NS Congestive heart failure15.29.118.2NS Atrial Fibrillation7.69.16.8NS Peripheral arterial disease12.19.113.6NS COPD6.109.1NSMarried, %60.963.659.5NSHigher education level, % Before ninth grade77.881.875.6NS Up to high school15.918.214.6 College/University6.309.8Laboratory values eGFR, (ml/kg/1.73m2)16 ± 714 ± 617 ± 7NS Creatinine (mg/dL)4.1 ± 1.74.4 ± 1.64.0 ± 1.8NS Urea (mg/dL)124 ± 50127 ± 47123 ± 52NS Potassium (mmol/L)4.7 ± 0.74.7 ± 0.74.7 ± 0.7NS Albumin (g/dL)4.0 ± 0.64.1 ± 0.64.0 ± 0.6NS Phosphorus (mg/dL)5.0 ± 2.15.3 ± 2.44.9 ± 2.0NS PTH (pg/mL)177 (107, 292)215 (112, 265)153 (98, 298)NS Total Calcium (mg/dL)9.2 ± 0.89.0 ± 1.09.3 ± 0.7NS 25-hydroxyvitamin D (ng/mL)23.5 ± 11.320.8 ± 1425.2 ± 9.2NS Bicarbonate (mmol/L)21.4 ± 6.320.3 ± 8.522.1± 4.6NS Alkaline phosphatase (UI/L)103 ± 61114 ± 4498 ± 69NS Iron (μg/ml)68.6 ± 28.875 ± 4165 ± 20NS Ferritin (ng/ml)176 (79, 394)121 (65, 368)209 (92, 408)NS Hemoglobin (g/L)11.0 ± 2.810.9 ± 3.111.1 ± 2.6NSeGFR estimated glomerular filtration rate, COPD chronic obstructive pulmonary disease, NS not significant

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Decision-making process in the pre-dialysis CKD patients: do anxiety, stress and depression matter?

Study design awaiting verification · BMC Nephrology · 2018

Original publication title

Decision-making process in the pre-dialysis CKD patients: do anxiety, stress and depression matter?

Cicero Italo L. Bezerra; Bruno C. Silva; Rosilene M. Elias

© The Author(s). 2018

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Depression, anxiety and perceived stress during final stages of CKD do not seem to be related to the choice of dialysis therapy and tend to decrease after dialysis initiation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The transition from pre-dialysis chronic kidney disease (CKD) to renal replacement therapy (RRT) is a stressful event. Anxiety, depression and stress are frequent conditions in this population, and might play a role on the choice of dialysis modality.

Source: Background

Abstract: What methods does the paper describe?

This is a prospective study that included stages 4-5 CKD patients during a dialysis multi-disciplinary education program. Demographic, clinical, and laboratory data were evaluated. Hospital Anxiety and Depression Scale and a Perceived Stress Scale assessed levels of anxiety, depression and stress, respectively.

Source: Methods

Abstract: Results

A total of 67 from 190 recruited patients were included (59 ± 15 years, 54% males). Comparing patients who chose peritoneal dialysis (PD) and hemodialysis (HD), there were no differences on anxiety (p = 0.55), and depression scores (p = 0.467), and stress (p = 0.854). Anxious (p = 0.007) and depressive (p = 0.030) patients presented lower levels of phosphate than those not affected. There was a significant correlation (p < 0.0001) between anxiety and depression scores (R2 = 0.573), anxiety and stress scores (R2 = 0.542), depression and stress scores (R2 = 0.514).

At the end of study, 29.8% of patients had already started on dialysis, and scores of anxiety, depression and stress reduced significantly (all p values < 0.0001), from 5.9 ± 3.3 to 1.8 ± 1.8, from 7.7 ± 4.0 to 3.8 ± 2.9 and from 28.6 ± 7.8 to 10.0 ± 6.2, respectively, regardless of which therapy was chosen.

Source: Results

Abstract: Conclusion

Depression, anxiety and perceived stress during final stages of CKD do not seem to be related to the choice of dialysis therapy and tend to decrease after dialysis initiation.

Source: Conclusion
Authors’ abstract

Background

The transition from pre-dialysis chronic kidney disease (CKD) to renal replacement therapy (RRT) is a stressful event. Anxiety, depression and stress are frequent conditions in this population, and might play a role on the choice of dialysis modality.

Methods

This is a prospective study that included stages 4-5 CKD patients during a dialysis multi-disciplinary education program. Demographic, clinical, and laboratory data were evaluated. Hospital Anxiety and Depression Scale and a Perceived Stress Scale assessed levels of anxiety, depression and stress, respectively.

Results

A total of 67 from 190 recruited patients were included (59 ± 15 years, 54% males). Comparing patients who chose peritoneal dialysis (PD) and hemodialysis (HD), there were no differences on anxiety (p = 0.55), and depression scores (p = 0.467), and stress (p = 0.854). Anxious (p = 0.007) and depressive (p = 0.030) patients presented lower levels of phosphate than those not affected. There was a significant correlation (p < 0.0001) between anxiety and depression scores (R2 = 0.573), anxiety and stress scores (R2 = 0.542), depression and stress scores (R2 = 0.514).

At the end of study, 29.8% of patients had already started on dialysis, and scores of anxiety, depression and stress reduced significantly (all p values < 0.0001), from 5.9 ± 3.3 to 1.8 ± 1.8, from 7.7 ± 4.0 to 3.8 ± 2.9 and from 28.6 ± 7.8 to 10.0 ± 6.2, respectively, regardless of which therapy was chosen.

Conclusion

Depression, anxiety and perceived stress during final stages of CKD do not seem to be related to the choice of dialysis therapy and tend to decrease after dialysis initiation.

Publication and source details

Original title: Decision-making process in the pre-dialysis CKD patients: do anxiety, stress and depression matter?

Cicero Italo L. Bezerra; Bruno C. Silva; Rosilene M. Elias

BMC Nephrology · 2018

© The Author(s). 2018https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:11:27.945962+00:00

DOI: 10.1186/s12882-018-0896-3 · PMC5921781